Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2023-04-25 00:00:00 ET · period of report 2023-04-21 · accession 0001415889-23-006833 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-04-25 | 2023-04-21 | PTCT | Utter Christine Marie | SVP, CAO, Fin | M - OptEx | $33.02 | +4,692 | 38.4K | +14% | +$154.9K |
| DM | 2023-04-25 | 2023-04-21 | PTCT | Utter Christine Marie | SVP, CAO, Fin | S - Sale+OE | $55.06 | -4,692 | 38.1K | -11% | -$258.3K |
| DM | 2023-04-25 | 2023-04-21 | PTCT | Utter Christine Marie | SVP, CAO, Fin | M - OptEx | $33.02 | -4,692 | 0 | -100% | -$154.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-21 | M | A | 4,321 | $33.02 | 42,380 | D | — | — | |
| 2 | Common | Common Stock | 2023-04-21 | S | D | 4,321 | $55.05 | 38,059 | D | — | — | (F2) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $54.50 to $55.49 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2023-04-21 | M | A | 371 | $33.02 | 38,430 | D | — | — | |
| 4 | Common | Common Stock | 2023-04-21 | S | D | 20 | $55.64 | 38,059 | D | — | — | |
| 5 | Common | Common Stock | 2023-04-21 | S | D | 351 | $55.09 | 38,079 | D | — | — | (F2) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $54.50 to $55.49 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 6 | Derivative | Stock Option (Right to Buy) | 2023-04-21 | M | D | 371 | $33.02 | 0 | D | $33.02 · — to 2029-01-21 | 371 Common Stock | (F3) Currently exercisable. |
| 7 | Derivative | Stock Option (Right to Buy) | 2023-04-21 | M | D | 4,321 | $33.02 | 0 | D | $33.02 · — to 2029-01-21 | 4,321 Common Stock | (F3) Currently exercisable. |